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ARTICLES
STOPPING EMBRYO RESEARCH
Ronald M. Greent
ETHICALLY MOTIVATED EFFORTS to slow or stop
programs of scientific research are relatively new. Harbingers of
this development are found in the physical sciences. During the
early 1950s, some leading scientists raised their voices in an effort
to halt development of the thermonuclear "Superbomb."' These
and later campaigns against anti-ballistic missile (ABM) develop-
ment programs were typically directed against applied science and
weapons initiatives rather than basic scientific research itself. For
attempts to halt basic research, we must turn to the life sciences.
Beginning with controversies surrounding recombinant DNA re-
search in the late 1970s,2 fetal tissue and embryo research in the
1980s,3 and research on human cloning, 4 and the genetic bases of
t Ronald M. Green is the Eunice and Julian Cohen Professor for the Study of
Ethics and Human Values and Director of the Ethics Institute at Dartmouth College
in Hanover, New Hampshire.
For a discussion of the superbomb controversy, see HERBERT F. YORK, THE
ADVISORS: OPPENHEIMER, TELLER, AND THE SUPERBOMB 41 (1976).
2 See, e.g., SHELDON KRIMSKY, GENETIc ALCHEMY: THE SOCIAL HISTORY OF
THE REcOMBINANT DNA CoNTRovERsY (1982) (examining the concerns surrounding
the scientific use, development, and application of gene-transplantation research).
3 For a review of the fetal tissue disputes, see, e.g., Steven Maynard-Moody,
Managing Controversies Over Science: The Case of Fetal Research, 5 J. PUBLIC
ADMIN., RES. & THEORY 5 (1995) (examining the twenty-year fetal research contro-
versy); Anita Stuhmcke, The Legal Regulation of Fetal Tissue Transplantation, 4 J.
L. & MED. 131 (1996) (questioning whether a legislative approach to regulating fetal
tissue transplantation is preferable to the Australian National Health and Medical
Research Council guidelines); Nildi Melina Constantine Bell, Regulating Transfer
and Use of Fetal Tissue in Transplantation Procedures: The Ethical Dimensions, 20
AM. J. L. & MED. 277 (1994) (exploring the political, social, and ethical implication
of fetal tissue transplantation). For an overview of the ethical and historical issues
surrounding human embryo research, see 1 REPORT OF THE HUMAN EMBRYO RE-
SEARCH PANEL (1994) (examining the moral status of the pre-implantation human
embryo); 2 NATIONAL INSTITUTES OF HEALTH: REPORT OF THE HUMAN EMBRYO
RESEARCH PANEL (1994) (providing papers commissioned for the NIH Panel).
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sexual orientation in the 1990s, 5 voices have been raised arguing
that whole lines of research ought not to be funded or even al-
lowed.
It will be the job of future historians to answer fully the ques-
tion of why life sciences research in the areas of genetics and re-
production has become a focal point of attack. My objective here
is more limited. I want to show how this broad wave of opposition
has impeded human embryo research. In my conclusion I will try
to offer some very preliminary answers to the question of why the
life sciences in particular have become objects of suspicion. I will
also consider what is legitimate and what is morally disturbing
about these attacks on a domain of scientific research.
This discussion is organized around four questions. First,
what do we mean by human embryo research? Second, what ef-
forts have been made to stop it? Third, what have been the conse-
quences of these efforts? Finally, in terms of ethics, how are we to
understand and assess this history of research obstruction?
I. WHAT DO WE MEAN BY HUMAN EMBRYO
RESEARCH?
We can define embryo research as the systematic study of a
fertilized human ovum that has never been transferred to and has
not yet been implanted in a womb. Normally, this means an em-
bryo created by in vitro fertilization, although it can also refer to
fertilized ova that have been flushed from the uterus shortly after
conception and kept alive in vitro for purposes of study. The de-
fining features of this research entity are its existence ex utero and
its early stage of development. Embryos used in research are usu-
4 A recommendation of a five-year moratorium on human cloning was part of
the report and recommendations of the National Bioethics Advisory Commission. See
1 CLONING HUMAN BEINGS: REPORT AND RECOMMENDATION OF THE NATIONAL
BioETincs ADVISORY CoMMISSION (1997).
5 See Stella Hu et al., Linkage Between Sexual Orientation and Chromosome
Xq28 in Males But Not in Females, 11 NATURE GENETICS 248 (1995) (examining the
DNA linkage of two families that contained two homosexual siblings as well as het-
erosexual siblings); Angela M. L. Pattatucci & Dean H. Hamer, Development and
Familiality of Sexual Orientation in Females, 25 BEHAVIOR GENETICS 407 (1995)
(discussing "the possibility of using developmental criteria to differentiate between
inherited and cultural sources of variation in female sexual orientation"); J. Michael
Bailey, Sexual Orientation Revolution, 11 NATURE GENETICS 353 (1995) (discussing
a report of linkage between genetic makeup and sexual orientation and the controver-
sies surrounding the report); Udo Schtildenk et al., The Ethics of Genetic Research on
Sexual Orientation, HASTINGS CTR. REP., July-Aug. 1997, at 6; TIMoTHY F. MURPHY,
GAY SCIENCE: THE ETHIcs OF SEXUAL ORIENTATION RESEARCH (1997).
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ally in the first two weeks of development, before or just up to the
early processes of cellular differentiation, tissue formation, and the
appearance of rudimentary bodily form. In all these respects, em-
bryo research differs from fetal research or fetal tissue research,
which typically involves a later stage fetus in utero or following
abortion.
6
Understood this way, embryo research is very much a conse-
quence of the development of the technology of in vitro fertiliza-
tion (IVF) by Patrick Steptoe, Robert Edwards, and others during
the 1970s. This made possible the first systematic study of the live
human embryo from fertilization onward. At the same time, the
relatively low success rates of IVF increased demand for more
systematic research on fertilization and embryo development. To-
gether, these factors have made the issue of embryo research in-
creasingly important in law, ethics, and public policy.
II. WHAT EFFORTS HAVE BEEN MADE TO STOP
RESEARCH?
Early IVF researchers like Steptoe and Edwards met little op-
position, even though their studies involved activities that later
became very controversial. These activities included the deliberate
fertilization of oocytes for research purposes with no intent to
transfer the resulting embryos (the creation of so-called "research
embryos"). During this period, a small number of bioethicists pub-
lished criticisms of this research. The focus of these criticisms was
less on the manipulation of the embryo itself than on the possible
harms to children born as a result of these experimental proce-
dures. Conservative bioethicists like Paul Ramsey and Leon Kass
condemned efforts to develop IVF because they believed it im-
posed unknown risks on unconsenting children. In a widely dis-
cussed pair of articles published in the Journal of the American
Medical Association in 1974,7 Ramsey half-seriously expressed the
wish that the first child produced by IVF might be born deformed,
as a warning to those who would tamper with the reproductive
process.
6 See generally 45 C.F.R. § 46.203(c) (1998) (defining fetus as "the product of
conception from the time of implantation ... until a determination is made, following
expulsion or extraction of the fetus, that it is viable").
7 See Paul Ramsey, Shall We Reproduce? (pts. 1-2), 220 JAMA 1346, 1480,
1485 (1972) (concluding that "in vitro fertilization is unethical medical experimenta-
tion on possible future human beings").
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The first serious legal impediments to the progress of embryo
research arose in this country at the end of the 1970s. Responding
to the advent of IVF, Congress formed a special body, the Ethical
Advisory Board (EAB), to review and provide guidance for feder-
ally funded research on the human embryo. In late 1979, the EAB
issued its report containing a broad permission for such research
under federal auspices subject to guidelines and limitations indi-
cated in the report and to be implemented by the Board itself.8
However in 1979, before the EAB's recommendations could be put
into effect, political intervention stalled their implementation.
Later, the Reagan and Bush administrations, reflecting their base
of support in the anti-abortion movement, withheld funding for the
EAB and made no nominations to its membership. Together, the
legal requirement of EAB approval and the absence of a working
EAB created a defacto moratorium on Federal funding for embryo
research in this country.
This moratorium remained in effect until June 1993 when,
with a new Democratic administration in office, Congress passed a
law nullifying the earlier requirement of EAB approval. 9 To pro-
vide ethical guidance for this area before funding pending propos-
als, the National Institute of Health (NIH) voluntarily established a
special body, the Human Embryo Research Panel. The panel, on
which I served, began work in January 1994. It held five monthly
meetings in Washington. It was open to the public and it issued its
report in September of that year.' 0 On December 2, 1994, the Ad-
visory Council to the Director of NIH unanimously accepted the
report's recommendations, which strongly favored Federal support
for embryo research. Later that same day, President Clinton issued
a directive overruling one of the panel's recommendation: its per-
mission for the use of research embryos. Eventually, even this
limited disagreement with the panel's recommendations was over-
taken by initiatives in the new Republican-dominated Congress. In
1995, Congress used appropriations legislation to bar federal
8 See Protection of Human Subjects, 44 Fed. Reg. 35,033, 35,057 (1979) (dis-
cussing scientific, ethical, legal, and social aspects of in vitro fertilization and embryo
transfer).
9 See NIH Revitalization Act of 1993, Pub. L. No. 103-43, § 121(c), 107 Stat.
122, 133 (1993) (nullifying 45 C.F.R. 46.204(d), pertaining to Ethical Advisory
Boards).
10 See 1 NATIONAL INSTITUTES OF HEALTH, supra note 3, at v-vii (presenting an
analysis of "various areas of research involving the ex utero pre-implantation human
embryo").
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funding of any research that threatened the embryo's survival."
This included a ban on the use of embryos left over from infertility
research, most of which are destined to be discarded. Also barred
was research on parthenogenesis, 1 2 even though parthenotes, which
result from electrical or chemical stimulation of an oocyte, are not
embryos and cannot develop beyond several stages of cell division.
Outside the United States, the picture has been mixed. Many
European nations (and several states of Australia) ban research that
does not contribute to the embryo's survival.1 3 In the wake of the
Warnock Committee Report, Great Britain developed extensive
legislation permitting embryo research.' 4 The Human Fertilization
and Embryology Act of 1990 established a national board, which,
among other things, licenses specific research protocols, including
those that employ research embryos and parthenotes.15 In one im-
portant respect, however, the United States differs from Europe,
including Great Britain, where regulations govern all research on
the human embryo. In the United States, federal legislation and
guidelines ban only federally funded research. To date there has
been no federal legislation prohibiting or limiting research with
private funds. Some state laws expressly forbid embryo research,
11 See Pub. L. No. 104-34, 109 Stat. 293 (1995) (amending 28 U.S.C.A. § 1391
(1994)).12 Reproduction of organisms without conjunction of gametes of opposite
sexes. AM. HERITAGE DICTIONARY 905 (2nd College Ed. 1982).
13 See generally Infertility (Medical Procedures) Act of 1984 amended by
Infertility (Medical Procedures) (Amendment) Act 1987 (Vic., Australia) (regu-
lating a wide range of IVF activities including limiting practice of IVF to ap-
proved facilities, limiting availability to married women, regulating confidenti-
ality, providing for a Standing Review and Advisory Committee, and banning
commercial surrogacy; Reproductive Technology Act 1988 (South Australia)
(establishing Council on Reproductive Technology, providing a code of ethical
practice, establishing licensing procedures, prohibiting embryo flushing, cryo-
preservation beyond 10 years, and any research "detrimental to an embryo");
Law on the Protection of Embryos (Germany) (making it a criminal offense to
alter the genetic make-up of human germ cells, to fertilize human ova for re-
search, to do any destructive embryo research, or to engage in cloning.); see also
Law No. 35/1988 on Assisted Reproduction Procedures (Spain) (covering artifi-
cial insemination, IVF, and gamete intra-fallopian tube transfer, and formulating
provisions on research and experimentation in the most detailed law on the books
to date).
14 Report of the Committee of Inquiry into Human Fertilization and Embry-
ology (Mary Warnock, chair), (HMSO, London, CMND 9314, 1984) [hereinafter
Warnock Report]. For a further description of the findings of the Warnock Re-
port, see generally EMBRYO EXPERIMENTATION: ETHICAL, LEGAL, AND SOCIAL
IssuEs 188-89, 195 (Peter Singer et al., eds. 1990).
15 Human Fertilization and Embryology Act, 1990, ch. 37 (Eng.).
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whether public or private. Louisiana's law, for example, defines
the embryo as a "juridical person," 16 and requires that it be used in
research "solely for the support and contribution of the complete
development of human in utero implantation.' ' However, these
laws have not typically been enforced, and it is unclear whether
they could withstand constitutional scrutiny.1 8 A considerable
amount of embryo research transpires in this country in connection
with the flourishing infertility industry. Nevertheless, the ban on
federal funding means that embryo research has been almost en-
tirely excluded from support by the huge, federally funded bio-
medical research establishment, including the National Institute of
Child Health and Development, whose mandate would seem di-
rectly related to the impact of infertility research on mothers and
children.
I. WHAT HAVE BEEN THE CONSEQUENCES OF
THESE EFFORTS AT OBSTRUCTION?
A case can be made that this history of exclusion from federal
support in the United States and outright prohibitions elsewhere
has had minor impact. Infertility medicine - the area that most di-
rectly draws on the results of embryo research - has made sub-
stantial progress in the two decades since its inception. Not only
have maternal age-adjusted transfer success rates greatly im-
proved, but a host of new technologies - like assisted hatching19
and intracyptoplasmic sperm injection (ICSI)20 - have been devel-
oped to help couples suffering from infertility. Nevertheless, this
apparent record of success obscures very serious problems, in-
cluding lack of progress in key areas, serious iatrogenic health
problems associated with infertility medicine, and the turning over
16 LA. REV. STAT. ANN. § 9:123, (West 1991) (stating the legal capacity of an in
vitro fertilized human ovum).
17 See also id § 9:122 (stating the authorized uses of an in vitro human embryo).
18 See Lori B. Andrews, State Regulation of Embryo Research, in 1 REPORT OF
TE HUMAN EMBRYO RESEARCH PANEL, supra note 3, at 297, 303-05 (questioning the
constitutionality of laws restricting human embryo research).
19 "Hatching" occurs when an embryo is at the 64-cell stage. The zona pel-
lucida surrounding the pre-embryo is degraded by enzymes at this stage, fluid is
pumped into the prembryo, and it begins to increase in size and become hollow.
See EMBRYO EXPERIMENTATION, supra note 14, at 6.
20 ICSI is an alternate method of in vitro fertilization whereby a single
sperm cell is injected into the cytoplasm of a single ovum. See Sperm Microin-
jection (ICSI) (visited July 8, 1999) <http://www.infertility.ca/clinA/clinA333.
html>.
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of research initiatives in this area to a relatively unregulated pri-
vate industry.
Lack of progress in research is most evident in connection
with our basic understanding of the processes of fertilization, im-
plantation, and early embryological development. It is now estab-
lished that there is a very high rate of natural embryo loss due to
failure to implant. Up to two-thirds of all fertilized eggs do not
implant.21 The causes of this, including cytological, chromosomal,
or genetic anomalies in eggs and embryos, are poorly understood.
There is evidence that early embryos have complex mechanisms
for monitoring, and in some cases repairing, chromosomal abnor-
malities like polyploidy, although these mechanisms do not always
operate effectively. Understanding how these processes work or go
wrong not only can assist infertility medicine - by improving our
ability to predict the developmental competence of available em-
bryos - it a can also aid in the prevention of miscarriages and birth
defects. The impact of early embryological problems on the course
of established pregnancies is poorly understood as well. Recent
discovery of the role of folic acid deficiency in the causation of
neural tube defects illustrates the importance of research focused
on the earliest phases of the reproductive process. Finally, I should
note that embryo research is crucial to the development of im-
proved contraceptives. It is unfortunate that nearly forty years after
the development of the first birth control pills, contraceptive op-
tions for women around the world have not significantly improved,
and in some cases - with the withdrawal of the IUD and contra-
ceptive implants from many markets - have even regressed. Re-
search on embryos that will not be transferred is often the end
point of research on fertilization since what must be tested is the
ability of measures to block conception without inadvertent dam-
age to any of the embryos. Perhaps responding to the importance
of contraceptive research, lawmakers in Australia's Victoria State
who banned embryo research chose to utilize a definition of the
human embryo that marks its existence not from sperm penetration
of the zona pellucida, but from the later point of syngamy. This
had the effect of permitting some limited forms of contraception-
related research.
One can debate the importance of this lack of progress in key
medical areas, but there can be no debate about the seriousness of
the health risks associated with infertility medicine today. Both the
21 See EMBRYO EXPERIMENTATION, supra note 14, at 9 (estimating that
three out of each hundred eggs result in live birth).
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women involved in these procedures and the children produced by
them are regularly exposed to health risks as a result of the lack of
research. For women, the most direct threat is the use of powerful
stimulatory drugs needed to produce multiple ova for fertilization.
With the replacement of natural cycle stimulation in the 1980s, this
regimen has become the procedure of choice. Despite more than a
decade of use of these medications, however, studies have not yet
established their safety, and there have been repeated reports of
elevated rates of breast and ovarian cancer in women exposed to
multiple cycles of these medications. 22 The risks for children pro-
duced from eggs exposed to these drugs are unknown.
Embryo research can contribute to reducing these risks in
many ways. In vitro studies on eggs and research embryos can
shed light on the effects these stimulatory drugs have on embryo
development. Development of the technologies of oocyte freezing
and in vitro egg maturation would make it possible to avoid en-
tirely in vivo stimulation of a woman. By permitting clinicians to
remove a large store of immature eggs from a woman's ovaries
and develop them in vitro to the point of fertilization competence,
this technology could spare women the effects of stimulatory
medications while simultaneously improving the efficiency of re-
productive procedures. These research goals require both embryo
research and a willingness to perform the initial research on em-
bryos not intended for transfer.
Research might also reduce the risks to children produced
through infertility procedures. Because of a lack of resources for
coordinated multi-center studies of assisted reproductive tech-
niques, some newer procedures like ICSI, assisted hatching, or oo-
cyte reconstruction via nuclear transfer have been introduced with
little or no prior research into their safety for the resulting off-
spring. Not surprisingly, one recent study indicates that there is a
slight but significant increase in the rate of spontaneous sex-
chromosome anomalies among children born as a result of ICSI as
22 See Mary Anne Rossing et al., Ovarian Tumors in a Cohort or Infertile
Women, 331 N. ENG. J. MED. 771, 776 (1994) (concluding that the use of clomi-
phene, an infertility drug, may increase the risk of an ovarian tumor); Alice S. Whit-
temore et al., Characteristics Relating to Ovarian Cancer Risk: Collaborative Analy-
sis of 12 U.S. Case-control Studies, (pts. 1, 2, 4), AM. J. EPIDEMIOLOGY 1175, 1184,
1212 (examining the relationship between certain reproductive and hormonal char-
acteristics and ovarian cancer); Robert Spirtas et al., Fertility Drugs and Ovarian
Cancer: Red Alert or Red Herring, 59 FERT=rrY & STErILrry 291 (1993) (analyzing
a study which linked the use of fertility drugs with ovarian cancer).
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compared with the general neonatal population. 23 In all these areas,
studies utilizing human embryos can help answer safety questions
and improve the success rates of existing procedures.
The need to transfer multiple embryos to increase the chances
of a pregnancy also carries major risks for the resulting children.
In Europe and the United States, IVF has resulted in a great in-
crease in the number of higher order multiple births with their as-
sociated toll of birth defects and prematurity. 24 Some have charac-
terized this as a virtual epidemic that has boosted the census in
neonatal intensive care units (NICU) around the world and resulted
in a flood of NICU graduates with serious health problems and
enduring disabilities. Parents unwilling to face these risks have
sometimes opted to terminate one or more fetuses, a procedure
with its own toll of medical risks and moral and psychological suf-
fering. It can be argued that the problem here lies with infertility
medicine, not a lack of embryo research. Some have criticized this
whole area as stimulating unnecessary expectations on the part of
infertile people and as seeking to satisfy a desire for one's own
offspring that is not a valid aim of medicine? 5 I believe these criti-
cisms are wrong. Infertility medicine is just as legitimate as most
other medical services currently provided and widely accepted.
Wherever one stands in this debate, however, there is little doubt
that IVF will continue to be widely used and that the risks to chil-
dren will be ongoing. Embryo research can help reduce these risks.
By improving our ability to identify "implantation competent" em-
bryos, we can help reduce the need for multiple embryo transfers.26
The health benefits of this research are undeniable, immediate, and
very significant.
Finally, I note that the ban on federal funding for embryo re-
search has served to stimulate the entry of biotechnology corpora-
tions into this area. In the absence' of federal support, leading sci-
23 Andr6 C. Van Steirteghem, Outcomes of Assisted Reproductive Technology,
383 NEW ENG. J. MED. 194-95 (1998).
24 See, e.g., Pam Belluck, Heartache Frequently Visits Parents With Multiple
Births, N.Y. TIMES, Jan. 3, 1998, at Al (discussing the complications and statistics
surrounding multiple pregnancies and births).
2 See GENA CoREA Er AL., MAN-MADE WOMEN: How NEW REPRODUCTIVE
TECHNOLOGIES AFFECT WOMEN 12 (1987) (discussing the repercussions of reproduc-
tive technology); see also BARBARA KATZ ROTHMAN, RECREATING MOTHERHOOD:
IDEOLOGY AND TECHNOLOGY IN A PATRIARCHAL SOCIETY 74-81 (1989) (discussing
the concept of having a child of one's own).
26 See Jonathan van Blerkom, The History, Current Status and Future Direction
of Research Involving Human Embryos, in 1 REPORT OF THE HUMAN EMBRYO
RESEARCH PANEL, supra note 3, at 13-14.
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entists have turned to venture capital as a source of funding for
their work. In November 1998, scientists funded by Geron Corpo-
ration in Menlo Park, California, announced that they had devel-
oped ways of producing embryonic stem cells by fertilizing ova
left over from infertility procedures. 27 Stem cells like these are ca-
pable of producing a host of bodily tissues for transplantation.
Less than a week later, researchers at Advanced Cell Technology,
a company based in Worcester, Massachusetts, announced that
they had produced human stem cells by inserting the nuclei of hu-
man somatic cells into enucleated cow eggs. 28 This cloning-related
technique promises to expedite greatly the production of histologi-
cally compatible stem cells for human tissue repair research, even
as it raises wholly new ethical questions about the appropriateness
of creating such transgenic embryos. Each company sought to as-
sure the public that there was ethical oversight of its work. In ad-
dition to requiring IRB approval of the research, for example, Ge-
ron formed a special ethics review board of its own to establish
research guidelines. 29 These guidelines were based upon the work
of the Human Embryo Research Panel, but unlike those proposed
for federally funded research, such corporate initiatives are en-
tirely voluntary. Since commercial interest in embryo research will
undoubtedly grow in the future, the withdrawal of federal funding
means a corresponding loss of federal ethical oversight.
IV. HOW ARE WE MORALLY TO ASSESS THIS
HISTORY OF RESEARCH OBSTRUCTION?
Most recent objections to embryo research stem from posi-
tions that view the early embryo as a research subject meriting all
the protections afforded live-born children. Although some people
who accept the right of abortion have opposed forms of embryo
research and the use of research embryos, the community of those
opposed to embryo research largely overlaps with the "right-to-
27 See Nicholas Wade, Scientists Cultivate Cells at Root of Human Life, N.Y.
TIMES, Nov. 6, 1998, at Al (explaining the process by which stem cells from in vitro
human embryos are being used to produce organs and aid in gene therapy, while
examining the ethical considerations).
28 See Nicholas Wade, Researchers Claim Embryonic Cell Mix of Human and
Cow, N.Y. TIMES, Nov. 12, 1998, at Al (explaining how a company has engineered a
human cell to its primordial, embryonic state by fusing it with cow eggs, and dis-
cussing the ethical considerations of human embryonic research).
29 See Andrew Pollack, Small Company Gains High Profile in the Scientific
World, N.Y. TIMES, Nov. 6, 1998, at A24 (explaining how Geron Corp. started and
developed as a medical research company).
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life" or anti-abortion movement. As a member of the Human Em-
bryo Research Panel, I can report that almost every speaker who
appeared before us opposing embryo research, as well as the or-
ganizations seeking to block NIB funding for this research, held
anti-abortion views. Those identified with this position regard the
embryo as morally equivalent to any other child or adult human
subject and believe that it cannot be involved in research proce-
dures that expose it to risk of injury or death unless these risks are
directly related to increasing the embryo's chances of survival.30
For many who hold this view, it is irrelevant that the embryo may
otherwise be doomed, as is the case of many frozen spare embryos
remaining from infertility procedures that will eventually be
thawed and discarded. Such embryos are viewed by those holding
this position as dying persons who cannot be subjected to harmful
procedures without their consent. Proxy consent by parents is also
presumably unacceptable in such cases since the law and ethics of
pediatric research normally permit parental permission for research
only when very low degrees of risk are involved.
Clearly, this position on the status of the embryo cannot le-
gally be a basis for banning embryo research in the United States.
Under U.S. law, the early embryo is not a juridical person. It is
considered to be bodily tissue under the control of its progenitors.
If a woman or couple wishes to donate gametes or embryos for the
purposes of embryo research, there would be major constitutional
obstacles preventing them from doing so, as some lower court
rulings have already implied.31 Without rehearsing here the com-
plex moral debate on human personhood and moral entitlements, I
believe that a very strong case can also be made that these legal
conclusions are ethically appropriate. The early embryo lacks most
30 Critics of embryo research who take this position do not usually indicate what
levels of risk this implies. One encounters here the complex philosophical question of
whether being born is itself a good for which it is worth assuming a substantial risk,
including the risk of illness and disability. This is sometimes called the "non-
identity" problem and has been widely discussed in connection with the work of the
philosopher Derek Parfit. See DEREK PARFIT, REASONS AND PERSONS 351-79 (1984).
The National Bioethics Advisory Commission identified this philosophical problem
and (properly, I believe) chose to bypass it in its assessment that current risk levels
ruled out efforts to clone a human being. See I CLONING HUMAN BEINGS: REPORT
AND RECOMMENDATION OF THE NATIONAL BIOETHICS ADVISORY COMMISSION, supra
note 4, at 65 (arguing that cloning should be prohibited at the present time because it
involves unaccepatble risks). For a discussion of my own views on the basis and
extent of our obligation to protect born children from harm, see Ronald M. Green,
Parental Autonomy and the Obligation Not to Genetically Harm One's Child Geneti-
cally, 25 J. L. MED. & ETmcs 5 (1997).
31 See Lori B. Andrews, supra note 18, at 303-05.
1999]
HEALTH MATRIX
of the qualities normally associated with the possession of basic
human rights. It is unreasonable to believe that its claims outweigh
those of its parent-progenitors or the health and safety of born
children and adult women. It follows that infertile couples wishing
to donate embryos for research aimed at improving the safety and
efficacy of procedures in which they are involved or for similar
biomedical research purposes should have the right to do so. Indi-
viduals or couples with a different view of the moral status of the
embryo should be permitted to withhold their own embryos from
such uses. They also have the right to try to persuade others of
their views. But they have no moral right to prohibit others from
donating their embryos for these purposes or to limit the right of
scientific researchers to pursue worthy areas of investigation. This
suggests that legal efforts to ban privately funded embryo research
are unjust and constitute a violation of public ethical responsibility
in a pluralistic democracy.
This leaves for ethical analysis only the very complex issue of
federal funding of embryo research. The consequences of efforts to
stop such funding are serious. The reduced progress of infertility
medicine and the potential iatrogenic and other health problems
that I have mentioned stem from the absence of federal funding.
As currently conducted, most embryo research takes place within
the context of privately supported infertility programs where the
resources for systematic and comprehensive research are extremely
limited. Most infertility programs depend on patient fees for finan-
cial support, leaving little room for research activities. The focus
on helping couples also drastically reduces the numbers of em-
bryos available for research, since most couples are unwilling to
donate embryos while caught up in the effort to establish a preg-
nancy. One solution to this is multi-center studies that increase the
number of embryos available for research, but such studies require
administrative coordination and financial support. With more than
three hundred infertility programs, in numerical terms the United
States is now the world's leading provider and consumer of infer-
tility services.32 The absence of federal funding for multi-center
studies is thus disproportionate to the amount of clinical activity
underway.
32 Society for Assisted Reproductive Technology, The American Society for
Reproductive Medicine, Assisted Reproductive Technology in the United States:
1996 Results Generated from the American Society for Reproductive Medi-
cine/Society for Assisted Reproductive Technology Registry, 71 FERTILITY &
STERILITY 798-807 (1999).
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In my view this situation is ethically unacceptable. It is un-
ethical to offer clinical medical services without simultaneously
engaging in the research needed to establish the efficacy and safety
of those services. In addition, a pluralistic democracy committed to
protecting and improving the health of its citizens cannot justly
exclude one area from its research support merely because that
area is objected to by some of its citizens on the basis of their per-
sonal religious and moral beliefs. Unless these religious and moral
objections can be grounded in concerns relevant to a pluralistic
democracy - and this means reasonably clear issues of public
health and safety - they must be set aside.
I realize that this position is not self-evident, and that I must
defend it. In doing so, I want first to dismiss as untenable the view
that no citizen should have to pay taxes for governmental research
activities to which she or he morally objects. This position, repeat-
edly expressed by presenters before the Human Embryo Research
Panel who objected to embryo research, makes no sense ethically
or legally. It is unreasonable and unworkable to subject funding
decisions, once made, to the multiple vetoes of dissenting citizens
or to ask only those in favor of specific public goods to pay for
them. Having to pay for programs with which we ethically dis-
agree is one consequence of living in a democracy.
Far more serious is the view that the federal funding of
health-related research programs can and should be made a matter
of majority decision. This, I take it, is the position of those who
believe that Congress has acted justly in banning NIH funding of
human embryo research. Those who hold this view appear to be-
lieve that the federal government and federal research establish-
ment can properly be dictated to regarding the programs they
choose to support primarily by the will of a majority of the people.
For those holding this view, issues of scientific merit or the likely
contribution of a research area to public health take a back seat to
preferences of voters. In addition, they see nothing wrong if these
preferences happen to be shaped by religious and moral views that
are not sustainable in terms of widely shared, public moral consid-
erations.
I believe this position is mistaken. Health-related research can
be a matter of life and death. In a just society, its direction and
governance is of the highest importance - in some instances on a
par with matters of basic constitutional liberties. It cannot be made
a matter of majority whim. This means that once a decision has
been made to fund health-related research, priority determinations
among research programs should be made in terms of scientific
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and public health considerations. This includes the use of inde-
pendent panels for peer review of the science and the use of other
multidisciplinary panels for assisting in policy decisions based on
the merit and worth of research directions. Public opinion can play
a role in this process and should by no means be excluded from it.
Recent AIDS and breast cancer activism shows that insulated fed-
eral panels can sometimes undervalue important research areas and
themselves become instruments of insensitive or discriminatory
majoritarian sentiments. Activists can awaken those involved in
these panels to their larger responsibilities. But political pressures
from any side must be filtered through a review process that privi-
leges scientific information and that identifies and promotes valid
public interests.
Reasoning by all those involved in these policy determina-
tions must proceed on the basis of what one writer has called
"public reason. 33 This means using arguments that appeal to basic
and widely shared human values and avoid appeal to religious or
moral claims not sustainable on common sense or evidential
grounds. Public values are those values necessary for the pursuit of
human ends in general. They include values like protection from
physical harms, liberty to pursue one's ends (including religious
ends consistent with other values), and access to at least a mini-
mum of financial goods needed and other means to be a partici-
pating member of the social order. Among these goods are the
benefits of publicly funded health-related research. The require-
ment that policy determination of such values be independent of
particular religious, theological, or philosophical beliefs does not
exclude the possibility that people's views may be deeply influ-
enced by such beliefs. However, once the public discussion of
policies begins, these beliefs must be capable of being articulated
in terms of the kinds of widely shared values that I mentioned. Fi-
nally, when actual issues, consequences, and claims are in dispute,
public discussion requires a weighing of arguments in the light of
reasoned analysis, the best available information and, where it is
available, scientific knowledge. Religious claims that cannot sus-
tain themselves in these terms should not play a role in these dis-
cussions.
33 See John Rawls, The Idea of Public Reason, in PoLmcAL LIBERALISM 212
(1993) (discussing the notion of public reason as the way in which a political society
formulates its plans, prioritizes results, and makes decisions); see also K.G. Gervais,
Speech at the Third Annual Symposium on Law, Religion, and Ethics, Hamline Uni-
versity Law School (Oct. 1990) (discussing the topic Moral Majoritarianism vs. Tol-
eration as the Basis of Public Policy).
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These general considerations apply to the issue of embryo re-
search. Currently, whole classes of research related to public
health and safety are supported by federal funds. Much of this
funding goes to areas that involve less risk to individuals than does
the field of reproductive medicine. To deny support of embryo re-
search amounts to unjustified political intervention in the research
prioritizing and funding process. It also amounts to arbitrary dis-
crimination against the women and children affected by poorly
researched reproductive medical procedures. Furthermore, this dis-
crimination is largely motivated not by reasonable public concerns
related to health and safety, but by publicly unsustainable religious
and ethical objections.
A hypothetical illustration suggested by the Swiss moral phi-
losopher Alex Mauron might help make the injustice of these ef-
forts more clear.34 Mauron asks us to think through the ethical
challenges surrounding those who hold idiosyncratic moral beliefs
by considering the situation of Jain religious believers living in a
liberal, pluralistic, and non-theological society. 35 As a matter of
deep religious conviction, Jains hold an extreme reverence for life.
They are strict vegetarians. Some devout Jains will sweep the
ground before them while walking to avoid killing small bugs.
Imagine, now, that Jains constitute a substantial part of the popu-
lation of the United States. To what extent should public policy
respect their position? To what extent should their position influ-
ence the course of biomedical research?
Mauron answers the first of these questions by observing that,
although the minority point of view that Jains represent cannot be
summarily dismissed, it should not be made a basis of public pol-
icy. In a society that values pluralism, such as ours, Jains should
certainly be free to practice their beliefs. They should also be free,
Mauron observes, "to try and persuade the rest of us to see things
their way." Nevertheless, "they cannot impose their views on non-
believers if they want to be peaceful participants in a secular social
order., 36 Attempting to do so would impose many serious risks on
34 See Alex Mauron, The Human Embryo and the Relativity of Biological Indi-
viduality, in CONCEIVING THE EMBRYO: ETHICS, LAW AND PRACTICE IN HUMAN
EMBRYOLOGY 55, 66-67 (Donald Evans ed., 1996) (discussing how the concept of the
individual is more an operational way to deduce moral decisions about the human
embryo, but does little to explain the concept substantively).
5 Jainism, founded in India in the 61h century, B.C., teaches immortality
and transmigration of the soul. See AM. HERITAGE DICTIONARY, supra note 12, at
685.
36 Id. at 67.
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non-believers (including exposure to disease or starvation) without
their consent and in the absence of reasons of compelling validity
to everyone. The parallel here to our own public reasoning about
the abortion question is clear. Legal impediments to abortion based
on strong views of fetal rights similarly represent the imposition of
serious risks on non-believers without their consent and in the ab-
sence of reasons of compelling validity to everyone.
Carrying this illustration a bit further, imagine that members
of the Jain minority have reluctantly agreed to accept this legal and
ethical status quo. Although they practice extreme reverence for
life (and even try peacefully to convert others to their beliefs), they
have decided for political and perhaps ethical reasons to respect
practices and institutions related to the use of animals for food by
other citizens. One such institution is the research on animals
needed to establish the safety of the food supply. This might in-
clude the administration of certain food additives or drugs to re-
search animals that are subsequently slaughtered for pathological
analysis. Consider, now, the ethical implications if some Jain
militants, unreconciled to the public rejection of their views, un-
dertook a campaign to block the use of animals in research. They
might try to argue that this research is not needed, that it is socially
dangerous because it erodes other widely shared values, or they
might openly argue from Jain premises that it is morally wrong.
This campaign, I believe, would be morally flawed in at least four
respects. First, it would violate the basic requirement of public
ethics in a pluralistic democracy that one not use the law to try to
impose one's non-publicly sustainable views on others. Second, it
would be dishonest. Unable to make a case for mandatory vege-
tarianism at the highest levels of public policy, these anti-research
activists would now be trying to accomplish their ends by means
of a "back door" approach at a point where public scrutiny of the
issues involved is likely to be less intense. Third, if this tactic
proved successful, it would impose special harms on people con-
suming animal products and might selectively injure those, the
poor or uneducated, who are unable to protect themselves by pri-
vately funded safety research. A final objection to this tactic is that
it corrupts the integrity of an independently established scientific
review process.
Analogies, Plato tells us, walk on weak legs. Some will dis-
pute that this imaginary illustration accurately parallels what has
transpired in the area of embryo research. I believe, however, that
it represents, point for point, a fully accurate description of the
basic moral issues and dynamics that have characterized this area.
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That this seems less evident to some people, I believe, can be
traced primarily to two factors. One is the absence of public fa-
miliarity with the urgent health and safety issues associated with
human embryo research. Lacking this understanding, which I and
other members of the Human Embryo Research Panel developed
over months of reading and listening, it is easy to dismiss embryo
research as a marginal activity related to a marginal and wholly
optional area of medical care, infertility medicine. I have tried to
suggest that this estimate is seriously mistaken. A second factor
contributing to the lack of urgency about obstruction of embryo
research is the widespread opposition to abortion in our society
and the willingness of many people to tolerate whatever tactics
further this opposition.
Other factors have played a contributory role to this history of
obstruction. Foremost among these, I suspect, is a widely shared
sense of discomfort with scientific intrusions in heretofore sacro-
sanct areas of reproduction. This discomfort has manifested itself
very clearly in public debates surrounding cloning, where even
liberal and progressive religious spokesmen have gone on record
as opposing tampering with the sources of human developmental
individuality and the dynamics of human parenting.
In the area of embryo research, this broad opposition to ma-
nipulating life's beginnings finds expression in the very negative
reception given the Human Embryo Research Panel's recommen-
dation that scientists be permitted deliberately to create and use
research embryos. This single recommendation was widely criti-
cized in the press and eventually afforded the Clinton White
House, which rejected this proposal, with an opportunity to stake
out a "moderate" position in the policy debate.
I will not here rehearse the many reasons why I believe this
opposition to the use of research embryos is unjustified. The Em-
bryo Research Panel's report details the many urgent and impor-
tant health issues that only studies based on the use of research
embryos can help us address. The ethical arguments for distin-
guishing between spare embryos and research embryos also do not
strike me as withstanding close scrutiny. This left an array of sym-
bolic considerations as the principal source of concern. These in-
clude the seeming violation of the Kantian injunction never to use
human beings as "means only," and the fear that this practice, in-
nocuous in itself, might lead to a more widespread instrumentali-
zation of human life. While recognizing the legitimacy of these
symbolic considerations, eighteen of nineteen panel members con-
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cluded that they are not weighty enough to warrant a prohibition of
research embryos.
I mention this debate because it suggests that concerns about
tampering with the sanctity of human life and parenthood do play a
contributory role in current efforts to stop life sciences research.
But, often, they are not the decisive consideration. Rather, the
greatest energy for this opposition is drawn from the two previous
factors that I mentioned: lack of sound knowledge of the implica-
tions of research obstruction, and opposition to anthing linked to
abortion.
Those who wish to preserve the freedom of life sciences re-
search in the areas of reproductive medicine and genetics must un-
derstand this array of forces. They must increase public under-
standing of the scientific and medical stakes by improving public
education in these areas. They must strive politically and adminis-
tratively to create a more protected environment for expert panels
in the policy process. Like other elements of our federal system,
for example, the Federal Reserve and FDA, scientific research
must be insulated from direct and unmediated control by powerful
political interest groups. Those wishing to preserve the freedom of
life science research must also work to counter the often-veiled
anti-abortion activism that intrudes on the policy process in these
areas, and they must make the public aware of the ethical implica-
tions of such intrusions. Above all, they must help renew our un-
derstanding of the ethical responsibilities we all share as citizens
in a pluralistic democracy. Personal dislike of research in a par-
ticular area, however sincerely motivated, must take second place
in all our thinking to respect for the independence of the scientific
research process and the protection of public health and safety.
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